Providence Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$2.94M |
| 2 |
Eaton
ETN
|
+$2.83M |
| 3 |
Kroger
KR
|
+$2.81M |
| 4 |
General Motors
GM
|
+$2.75M |
| 5 |
Merck
MRK
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.98M |
| 2 |
Baxter International
BAX
|
+$2.67M |
| 3 |
Cisco
CSCO
|
+$2.57M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$2.55M |
| 5 |
Verizon
VZ
|
+$2.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.35% |
| 2 | Financials | 11.06% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 9.18% |
| 5 | Energy | 9.12% |
Similar funds
Providence Capital Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Providence Capital Advisors held 256 positions worth $170M, up 0.96% from $169M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Providence Capital Advisors deployed $23.7M of net new capital in Q3 2019, opening 32 new positions and adding to 57 existing holdings. Its largest new stake was Eaton: 34,927 shares worth $2.9M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $2.55M trimmed.
- Providence Capital Advisors's largest Q3 2019 buy was Eaton: 34,927 shares worth $2.9M.
- Providence Capital Advisors added most to Target in Q3 2019, an estimated $2.94M increase.
- Providence Capital Advisors's biggest Q3 2019 reduction was Bristol-Myers Squibb, cutting an estimated $2.55M.
- Providence Capital Advisors fully exited Medtronic in Q3 2019, selling an estimated $2.98M.
- Providence Capital Advisors's ten largest holdings make up 22% of its $170M portfolio in Q3 2019.
- Providence Capital Advisors opened 32 new positions and closed 35 in Q3 2019.
- Providence Capital Advisors's portfolio value rose 0.96% quarter-over-quarter to $170M.
Based on Providence Capital Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.